News

Stevenage Bioscience Catalyst – celebrating 10 years of innovation

• Stevenage Bioscience Catalyst celebrates its 10th anniversary

• Events focus on the cutting-edge science of our occupier companies

• The campus is now at the heart of the biggest cluster for cell and gene therapy in Europe.

STEVENAGE 11th July 2022: Stevenage Bioscience Catalyst (SBC) is celebrating 10 years since it opened its doors to life sciences companies. A series of events was held on 6th July to celebrate the some of the breakthrough science being undertaken on campus including a science symposium, celebration lunch and scientific poster exhibition.

eNews July 2022

Please click here to read July's eNews

Funding competition - Fast Start: Innovation Opens Today

Innovate UK is offering small and micro businesses a share of up to £30 million in grants alongside tailored business support delivered by Innovate UK EDGE. You can apply for up to £50,000 for highly innovative ideas that have a clear route to commercialisation through business growth.

RevoluGen Wins 2022 BioNewsRound Award for Translational Research

First Automated Benchtop Fire Monkey HMW-DNA Extraction Installed at Quadram Institute for Pathogen Sequencing and AMR Monitoring

London, UK – 08 July 2022 – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), is pleased to announce that it has been selected as the winner of the 2022 BioNewsRound Award, for the development and automation of its Fire Monkey High Molecular Weight (HMW) DNA extraction system and successful transfer to its collaborator, Quadram Institute Biosciences (Quadram).

DIVERSA Technologies: New member and expert in pharmaceutical nanotechnology

Are you in need a drug delivery system to bring your candidate molecules inside the cell? Are you tired of long and tedious collaborations? Can you imagine being able to arrive at the clinic with your candidate molecule? DIVERSA helps you with your drug delivery challenges.

Stevenage Bioscience Catalyst – Developer named for campus expansion

• Further plans for Stevenage campus expansion shared

• Developer partners announced as Reef Group and UBS Asset Management

• GSK to gift land to SBC to enable expansion

STEVENAGE 4th July: Stevenage Bioscience Catalyst (SBC) is based on the life science campus in Stevenage, Hertfordshire. Details of plans to expand the campus were shared today.

Mogrify and Astellas Announce Collaboration to Conduct Research on In Vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss

05 July 2022

Cambridge, UK, Tokyo, Japan, 05 July 2022: Mogrify Limited (CEO: Darrin M. Disley, Ph.D., “Mogrify®”), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.

ARECOR ANNOUNCES PRESENTATION AT EASD 2022 OF PHASE I CLINICAL TRIAL OF AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN FOR DIABETES

Cambridge, UK, 4 July 2022: Arecor Therapeutics plc (AIM: AREC), a globally focused biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its abstract titled “Phase I study investigating PK and PD of highly-concentrated insulin aspart AT278 U500” has been selected for presentation as part of the Short Oral Discussion Session A at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) meeting, which will be held from 19-23 September 2022 in Stockholm, Sweden and online.

Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

Jun 28, 2022

Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates

One Nucleus and My Green Lab Collaborate to Drive Sustainable Change in Laboratories

Cambridge: 24 June 2022

One Nucleus is pleased to announce an exciting collaboration with My Green Lab to support its member organisations in becoming more sustainable. We will be sign-posting the ‘My Green Lab Certification’ complimentary program and providing a discount, exclusive to One Nucleus Members, for the Accredited Professional training courses.

My Account